OpenVSafe by OpenVAERS
Search V-safe

FAF-21544-02401

4 vaccinations 7 coded responses 18 check-ins 7 free-text entries 3 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
180 / PA
Registered
2021-04-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-14
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-08
    Registered in v-safe
  3. 2021-04-08
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-08
    Health check-in — day 0, dose 2
    Feeling: Fair · Fever · Headache, Fatigue or tiredness, Diarrhea
    Adult check-in
  5. 2021-04-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insomnia, Myoclonus — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Insomnia, myoclonic jerks
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  8. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  9. 2021-04-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-04-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Itching · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-04-15
    Survey response — day 7, dose 2
    MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Extreme menstrual pain and heavy flow
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-22
    Survey response — day 14, dose 2
    MedDRA: Abnormal menstrual clots, Arthralgia, Bone pain, Migraine, Myalgia, Weight decreased — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Increased menstrual clotting mid cycle; decreased appetite; weight loss; migraine; joint, bone, and muscle pain from fibromyalgia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-29
    Survey response — day 21, dose 2
    MedDRA: Fatigue, Office visit — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Extreme fatigue; low iron · Healthcare visit (other): In-person private appointment
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-29
    Report sent to call center — day 21, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-05-06
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  16. 2021-05-13
    Survey response — day 35, dose 2
    MedDRA: Iron deficiency anaemia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: IDA and symptoms from venofer infusions
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-20
    Survey response — day 42, dose 2
    MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Continued IDA and reax to Venofer infusions
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-05-20
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-07-08
    Health check-in — 3 months, dose 2
    Feeling: Poor
    Adult check-in
  20. 2021-10-07
    Health check-in — 6 months, dose 2
    Feeling: Poor
    Adult check-in
  21. 2021-11-10
    Dose 3 — Moderna
  22. 2022-04-07
  23. 2022-04-08
    Health check-in — 12 months, dose 2
    Feeling: Poor
    Adult check-in
  24. 2022-09-20
    Dose 4 — Janssen/Johnson & Johnson
  25. 2022-12-20
    Survey response — 3 months, dose 4
    MedDRA: Hysterectomy, Salpingectomy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Abnormal menstrual bleeding resulting in hysterectomy with bilateral salpingectomy
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-12-20
    Report sent to call center — 3 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  27. 2022-12-21
  28. 2023-03-21
    Health check-in — 6 months, dose 4
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-14Pfizer-BioNTech
22021-04-08Pfizer-BioNTech
32021-11-10Moderna No
42022-09-20Janssen/Johnson & Johnson No

Call center

3 call center cases

3 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-09

Systemic reaction (other): Insomnia, myoclonic jerks

Release 7 — day 7, dose 2

2021-04-15

Systemic reaction (other): Extreme menstrual pain and heavy flow

Release 7 — day 14, dose 2

2021-04-22

Symptoms: Increased menstrual clotting mid cycle; decreased appetite; weight loss; migraine; joint, bone, and muscle pain from fibromyalgia

Release 8 — day 21, dose 2

2021-04-29

Symptoms: Extreme fatigue; low iron
Healthcare visit (other): In-person private appointment

Release 8 — day 35, dose 2

2021-05-13

Symptoms: IDA and symptoms from venofer infusions

Release 8 — day 42, dose 2

2021-05-20

Symptoms: Continued IDA and reax to Venofer infusions

Release 12 — 3 months, dose 4

2022-12-20

Symptoms: Abnormal menstrual bleeding resulting in hysterectomy with bilateral salpingectomy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDAbnormal menstrual clots ✓ ✓ ✓
SDArthralgia ✓ ✓ ✓
SDBone pain ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHysterectomy · · ✓
SDIron deficiency anaemia ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDSalpingectomy · · ✓
SDWeight decreased ✓ ✓ ✓
SRODysmenorrhoea ✓ ✓ ✓
SROHeavy menstrual bleeding ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓
SROMyoclonus ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release